Menu
Not yet recruiting NCT07718022

Caregiver-Adolescent Dating Violence Prevention Intervention Pilot Trial

No phase Interventional Adolescent Relationship Abuse Sexual and Gender Minorities

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: FLARE, Resource Guide.
Who it may be relevant to
Registry conditions: Adolescent Relationship Abuse, Sexual and Gender Minorities. Basic parameters: from 14 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Relationship Abuse Prevention Intervention Implemented With Sexual and Gender Diverse Youth and Their Caregivers - Pilot Trial

Overview

This is a pilot clinical trial to test an intervention called FLARE, which is an adolescent relationship abuse prevention program for sexual and gender diverse youth and their trusted adults. FLARE comprises in-person, virtual, and asynchronous programming developed by and for caregivers and adolescents.

Detailed description

In this pilot trial, the investigators will be testing FLARE, a dating violence prevention program for sexual and gender diverse youth and their trusted adults. The study will be comparing FLARE to a wait-list control. This trial will focus on assessing acceptability, feasibility, and fidelity, as well as exploratory changes in behavioral outcomes. FLARE includes 1 in-person full day session, 2 virtual large group sessions, and several asynchronous components (website, workbook, card game). FLARE runs over a 4 week period.

Interventions

  • Behavioral FLARE
    Adolescent relationship abuse prevention intervention for sexual and gender diverse youth and their trusted adults
  • Behavioral Resource Guide
    The control group will receive a resource guide and then will be able to receive FLARE after the trial is complete as a wait list control option

Primary outcome measures

  • Acceptability [Time frame: T2 (1 month post baseline)]
  • Trial Feasibility [Time frame: T1 (baseline); T2 (1 month post baseline); T3 (3 months post baseline, 2 months post T2)]
Secondary outcome measures (12)
  • Attitudes about abusive behaviors [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Attitudes towards diverse identities [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Self-efficacy [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Parenting confidence [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Caregiver self-efficacy [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Motivation [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Resource utilization [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Dating related parenting monitoring [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Parenting monitoring [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • LGBTQ Caregiver [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • parent-adolescent communication [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]
  • Adolescent relationship abuse [Time frame: T1 (baseline); T3 (3 months post baseline, 2 months post T2)]

Eligibility criteria

Inclusion criteria

  • SGDY eligibility includes:
  • ages 14 to 18
  • identifies as sexually or gender diverse (e.g., gay, lesbian, bisexual, queer, transgender, or nonbinary)
  • uses English
  • willing to travel to Pittsburgh for 1 in-person event; and
  • can identify a caregiver who can also participate.

Caregivers eligibility includes:

  • age 18 or older;
  • a caregiver of an SGDY ages 14 to 18;
  • uses English;
  • willing to travel to Pittsburgh for 1 in-person event; and
  • has a child participating in this study. Caregivers can include parents or any other person whom the adolescent identifies as a trusted adult in their life. We will only enroll 1 caregiver for each SGDY; because this is a dyadic study each adolescent needs a matched participating caregiver and vice versa.

Exclusion criteria

  • Does not meet eligibility criteria
  • Incarcerated during the study
  • Unable to provide verbal or REDCap consent or assent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • University of Pittsburgh — Pittsburgh

Identifiers

NCT: NCT07718022 · STUDY25020077

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗